Effect of paliperidone palmitate 3-month formulation on goal attainment and disability after 52 weeks’ treatment in patients with clinically stable schizophrenia

  1. Lambert, M.
  2. Sanchez, P.
  3. Bergmans, P.
  4. Gopal, S.
  5. Mathews, M.
  6. Wooller, A.
  7. Pungor, K.
Zeitschrift:
Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Datum der Publikation: 2020

Ausgabe: 16

Seiten: 3197-3208

Art: Artikel

DOI: 10.2147/NDT.S286654 GOOGLE SCHOLAR lock_openOpen Access editor